SUN VALLEY, Calif., Aug. 16, 2007 (PRIME NEWSWIRE) -- Summus Works, Inc. (Pink Sheets:SMMW), due to its recent acquisition of BioPharmetics assets and business operations, announced today the company's plan of operations.
The company released the following statement: "As BioPharmetics, Inc. has increasingly worked on offering solutions to the healthcare arena, it is important to continue on this path for the benefit of the company and its shareholders. We intend to focus considerable interest in offering solutions for diabetic care. A recent study by the National Changing Diabetes Program, states that 12% of total federal healthcare was spent on Diabetes. That translates into a $645 billion marketplace here in the U.S. alone," stated Mr. Dan Burgess, CEO of Summus. "The solutions the company offers are cutting-edge, appeal to managed care companies, and give the physician or healthcare coordinator, information to deliver the highest quality of patient care possible in today's healthcare environment."
About Summus Works, Inc.
Summus Works recently closed an acquisition for the assets and business operations of BioPharmetics, Inc. Through this acquisition, the company will have the ability to market and sell a myriad of healthcare, anti-aging, and cosmeceutical products to healthcare companies, retail and wholesale companies, as well targeting certain sectors of healthcare, biotechnology, and cosmetics.
The Summus Works, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4093
For more information visit http://www.biopharmetics.com.
This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.